npj Precision Oncology · 2024 · 10 citations · 25 references
MedicineBiochemistryCancer BiologyCarcinogenesisHepatologyMetabolic RegulationCirrhosisHepatic MetabolismHepatocellular CarcinomaLipid MetabolismLiver CancerLiver DiseaseHepatic Lipid AccumulationHepatic Lipid MetabolismHepatocellular Carcinoma MetastasisHepatocellular Carcinoma PathogenesisLiver LipogenesisLiver Metabolism RegulationMechanismsViral Hepatitis-related Cirrhosis
Abnormal lipid metabolism promotes hepatocellular carcinoma (HCC) progression, which engenders therapeutic difficulties owing to unclear mechanisms of the phenomenon. We precisely described a special steatotic HCC subtype with HBV-related cirrhosis and probed its drivers. Hematoxylin-eosin (HE) staining of 245 HCC samples revealed a special HCC subtype (41 cases) characterized by HBV-related cirrhosis and intratumoral steatosis without fatty liver background, defined as steatotic HCC with HBV-related cirrhosis (SBC-HCC). SBC-HCC exhibits a larger tumor volume and worse prognosis than non-SBC-HCC. Screening for driver genes promoting fatty acid (FA) biosynthesis in the Gao's HBV-related cirrhosis HCC cases and GSE121248' HBV-related HCC cases revealed that high expression of SOCS5 predicts increased FA synthesis and that SOCS5 is upregulated in SBC-HCC. Through proteomics, metabolomics, and both in vivo and in vitro experiments, we demonstrated that SOCS5 induces lipid accumulation to promote HCC metastasis. Mechanistically, through co-IP and GST-pulldown experiments, we found that the SOCS5-SH2 domain, especially the amino acids Y413 and D443, act as critical binding sites for the RBMX-RRM domain. SOCS5-RBMX costimulates the promoter of SREBP1, inducing de novo lipogenesis, while mutations in the SH2 domain, Y413, and D443 reverse this effect. These findings precisely identified SBC-HCC as a special steatotic HCC subtype and highlighted a new mechanism by which SOCS5 promotes SBC-HCC metastasis.
25
Naga Chalasani, Zobair M. Younossi, Joel E. Lavine et al. · Hepatology · 2012 · 3.8K citations
Targeting metastasis-initiating cells through the fatty acid receptor CD36
Gloria Pascual, Alexandra Avgustinova, Stefania Mejetta et al. · Nature · 2016 · 1.4K citations
Medicine, Cancer Biology, Oncology +14
SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth
Thomas Porstmann, Cláudio R. Santos, B Griffiths et al. · Cell Metabolism · 2008 · 1.4K citations · Full text